Escalon Medical Corp. (ESMC)

Escalon Medical Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	12.05	11.98	12.18	10.7	10.47
Revenue Growth (YoY)	0.54%	-1.63%	13.80%	2.21%	11.40%
Cost of Revenue	6.54	6.84	6.7	6.1	6.04
Gross Profit	5.51	5.15	5.48	4.61	4.43
Selling, General & Admin	4.62	4.56	4.18	4.09	3.57
Research & Development	0.75	0.69	0.82	0.99	0.89
Operating Expenses	5.38	5.25	5	5.08	4.46
Operating Income	0.13	-0.1	0.48	-0.47	-0.03
Interest Expense	-0.02	-0.02	-0.02	-0.02	-0.02
Interest & Investment Income	-	-	-	0	0
Other Non Operating Income (Expenses)	-0.01	-	-	-	0
EBT Excluding Unusual Items	0.11	-0.13	0.46	-0.49	-0.05
Other Unusual Items	-	-	-	0.51	-
Pretax Income	0.11	-0.13	0.46	0.02	-0.05
Earnings From Continuing Operations	0.11	-0.13	0.46	0.02	-0.05
Net Income	0.11	-0.13	0.46	0.02	-0.05
Preferred Dividends & Other Adjustments	0.08	0.05	0.24	0.05	0.05
Net Income to Common	0.03	-0.18	0.22	-0.03	-0.1
Net Income Growth	-	-	2426.55%	-	-
Shares Outstanding (Basic)	7	7	7	7	7
Shares Outstanding (Diluted)	14	7	14	7	7
Shares Change (YoY)	92.20%	-45.33%	82.92%	-	-
EPS (Basic)	0.00	-0.02	0.03	-0.00	-0.01
EPS (Diluted)	0.00	-0.02	0.03	-0.00	-0.01
Free Cash Flow	0.38	-0.64	0.32	-1.05	0.83
Free Cash Flow Per Share	0.03	-0.09	0.02	-0.14	0.11
Gross Margin	45.75%	42.95%	45.00%	43.04%	42.28%
Operating Margin	1.11%	-0.87%	3.93%	-4.39%	-0.32%
Profit Margin	0.23%	-1.48%	1.82%	-0.31%	-0.99%
Free Cash Flow Margin	3.13%	-5.37%	2.61%	-9.81%	7.92%
EBITDA	0.17	-0.06	0.52	-0.42	0.01
EBITDA Margin	1.42%	-0.49%	4.30%	-3.94%	0.11%
D&A For EBITDA	0.04	0.05	0.05	0.05	0.04
EBIT	0.13	-0.1	0.48	-0.47	-0.03
EBIT Margin	1.11%	-0.87%	3.93%	-4.39%	-0.32%
Revenue as Reported	12.05	11.98	12.18	10.7	10.47
Advertising Expenses	-	-	-	-	0

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.